Back to Journals » Clinical and Experimental Gastroenterology » Volume 13

Changes in Function and Dynamics in Hepatic and Splenic Macrophages in Non-Alcoholic Fatty Liver Disease

Authors Fukushima H, Kono H, Hirayama K, Akazawa Y, Nakata Y, Wakana H, Fujii H

Received 6 February 2020

Accepted for publication 27 July 2020

Published 21 August 2020 Volume 2020:13 Pages 305—314


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Editor who approved publication: Professor Andreas M. Kaiser

Hisataka Fukushima,1 Hiroshi Kono,1 Kazuyoshi Hirayama,1 Yoshihiro Akazawa,1 Yuuki Nakata,1 Hiroyuki Wakana,1 Hideki Fujii1,2

1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan; 2Department of Surgery, Kofu Municipal Hospital, Yamanashi, Japan

Correspondence: Hiroshi Kono Email

Background: The aim of this study was to investigate the populations and functions of hepatic and splenic macrophages (Mfs) in non-alcoholic fatty liver disease (NAFLD).
Materials and Methods: Experiment 1: Wild-type and STAM® mice were given chow or high-fat diets for designated periods. In isolated Mfs, phagocytosis and cytokine production were assessed. Immunohistochemistry for CD68 and F4/80 and expression of CD14 and CD16 were assessed. Experiment 2: Bone marrow cells harvested from enhanced green fluorescent protein (EGFP) mice were transplanted into wild-type mice with or without splenectomy after total body irradiation that was kept on methionine- and choline-deficient diets.
Results: Experiment 1: The number of CD68-positive cells and the percentage of F4/80-positive/CD68-positive cells increased with the progression of NAFLD. Production of TNF-α and IL-6 by hepatic Mfs was greater than that by splenic Mfs in mice with NASH. The number of CD14+CD16 Mfs increased in the spleen and decreased in the liver in animals that had progressed to NASH. Furthermore, the number of CD14+CD16+ hepatic Mfs was increased in animals that had progressed to NASH with fibrosis. Experiment 2: EGFP-positive cells were observed in the liver after transplantation. In the splenectomy group, EGFP-positive Mfs were also observed; however, the number was significantly less than that in the sham operation group.
Conclusion: The populations and functions of hepatic and splenic Mfs are altered during the progression of NAFLD. In addition, increased hepatic Mfs during the progression of NAFLD may migrate from bone marrow to the liver via the spleen.

Keywords: tissue macrophage, NASH, NAFLD, M1-type macrophage, bone marrow transplantation, EGFP mouse, STAM mouse

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]